• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SLGL

SLGL

Sol-Gel Technologies Ltd.

NASDAQHealthcareBiotechnologyIL

USD71.50

-2.23 (-3.02%)

Rating:C

Company Profile

CEO

Moshe Arkin

IPO Date

2018-02-01

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

IL

Market Metrics

Open

$72.89

Prev. Close

$73.73

Day Low

$70.42

Day High

$77.98

52W Low

$6.80

52W High

$97.97

Market Cap

$0.20B

Volume

0.03M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

61.2%

Avg Negative

2.2%

Avg Neutral

36.8%

News Feed

Sol-Gel Wins FDA Approval For Fixed-Dose Combination Of Tretinoin, Benzoyl Peroxide For Acne Vulgaris

Benzinga·7/27/2021·↑ positive

Sol-Gel Technologies Announces FDA Approval of TWYNEO®

GlobeNewsWire·7/27/2021·↑ positive

Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021

GlobeNewsWire·
7/20/2021
·↑ positive

Sol-Gel Announces Pipeline Update and Future Development Plans

GlobeNewsWire·6/28/2021·↑ positive

Sol-Gel Technologies and Galderma Announce Exclusive Licenses for the Commercialization of EPSOLAY® and TWYNEO® in the United States

Business Wire·6/28/2021·↑ positive

Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update

GlobeNewsWire·5/13/2021·↑ positive

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sol-Gel Technologies Ltd. - SLGL

PRNewsWire·4/28/2021·↓ negative

Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY®

GlobeNewsWire·4/27/2021·↑ positive

SolGel Technologies Ltd. (SLGL) Moves 9.7% Higher: Will This Strength Last?

Zacks Investment Research·4/16/2021·↑ positive

SolGel Technologies Ltd. (SLGL) Stock Jumps 10.8%: Will It Continue to Soar?

Zacks Investment Research·3/11/2021·↑ positive